MERCK&CO

Merck & Co., Inc. (known as MSD outside the United States and Canada) in India is a global healthcare company. It operates with a comprehensive business model, engaging in both manufacturing and commercial activities.

It is both a factory and a trading company.

In India, Merck & Co. (MSD) has a significant presence that includes:

* Manufacturing facilities for producing pharmaceuticals and vaccines.

* Research and development operations.

* Sales, marketing, and distribution of its pharmaceutical products, vaccines, and animal health products.

Therefore, its operations in India encompass manufacturing (factory) as well as sales and distribution (trading/commercial activities).

Merck & Co. (known as MSD outside the United States and Canada) operates in India primarily in the pharmaceutical and vaccine sectors. Their product portfolio in India includes:

- Keytruda (pembrolizumab) for oncology

- Gardasil and Gardasil 9 (Human Papillomavirus Vaccine)

- Pneumovax 23 (Pneumococcal Polysaccharide Vaccine)

- RotaTeq (Rotavirus Vaccine, Live, Oral)

- Varivax (Varicella Virus Vaccine Live)

- MMR II (Measles, Mumps, Rubella Virus Vaccine Live)

- Januvia (sitagliptin) for type 2 diabetes

- Janumet (sitagliptin and metformin hydrochloride) for type 2 diabetes

- Isentress (raltegravir) for HIV infection

- Zetia (ezetimibe) for high cholesterol

- Vytorin (ezetimibe and simvastatin) for high cholesterol

- Bridion (sugammadex) for reversal of neuromuscular blockade